MarketPulse
N

$NMRA

2 articles found
1 positive
1 negative
0 neutral
BenzingaBenzinga··Schall Law Firm

Neumora Therapeutics Faces Securities Fraud Investigation Over Disclosure Violations

The Schall Law Firm investigates Neumora Therapeutics ($NMRA) for potential securities fraud involving false statements or material information omissions.
NMRAclass action lawsuitshareholder rights
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Neumora to Unveil 2025 Results as Pipeline Advances Toward Critical Trial Readouts

Neumora Therapeutics will report 2025 financial results March 30, 2026, with major KOASTAL trial readouts anticipated in Q2 2026.
NMRAfinancial resultsclinical-stage biopharmaceutical